Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 13, 2012
In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damage
Holger P Behrsing, Michael J Furniss, Myrtle Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 26, 2023
An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays
Kimberly Rockley, Ruth Roberts, Hannah Jennings, et al.
Frontiers in Genetics
|
March 3, 2015
Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity
Myrtle Davis, Jianying Li, Elaine Knight, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 25, 2012
The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity
Karen Schweikart, Liang Guo, Zachary Shuler, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 25, 2017
Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics
Liang Guo, John Hamre, Sandy Eldridge, et al.
Toxicology and Applied Pharmacology
|
January 29, 2022
Mechanism of hepatobiliary toxicity of the LPA<sub>1</sub> antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
Michael W Gill, Brian J Murphy, Peter T W Cheng, et al.
Science Translational Medicine
|
June 24, 2016
Enhancing quality of life as a goal for anticancer therapeutics
Syril D Pettit, Steven E Lipshultz, Charles S Cleeland, et al.
Journal of the National Cancer Institute
|
September 12, 2014
Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities
Nonniekaye Shelburne, Bishow Adhikari, Joanna Brell, et al.
Lab on a Chip
|
August 31, 2019
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Garrett R Ainslie, Myrtle Davis, Lorna Ewart, et al.
Nature Reviews. Drug Discovery
|
October 30, 2010
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
Shivanni Kummar, Helen X Chen, John Wright, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 13, 2012
In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damage
Holger P Behrsing, Michael J Furniss, Myrtle Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 26, 2023
An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays
Kimberly Rockley, Ruth Roberts, Hannah Jennings, et al.
Frontiers in Genetics
|
March 3, 2015
Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity
Myrtle Davis, Jianying Li, Elaine Knight, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 25, 2012
The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity
Karen Schweikart, Liang Guo, Zachary Shuler, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 25, 2017
Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics
Liang Guo, John Hamre, Sandy Eldridge, et al.
Toxicology and Applied Pharmacology
|
January 29, 2022
Mechanism of hepatobiliary toxicity of the LPA<sub>1</sub> antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
Michael W Gill, Brian J Murphy, Peter T W Cheng, et al.
Science Translational Medicine
|
June 24, 2016
Enhancing quality of life as a goal for anticancer therapeutics
Syril D Pettit, Steven E Lipshultz, Charles S Cleeland, et al.
Journal of the National Cancer Institute
|
September 12, 2014
Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities
Nonniekaye Shelburne, Bishow Adhikari, Joanna Brell, et al.
Lab on a Chip
|
August 31, 2019
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Garrett R Ainslie, Myrtle Davis, Lorna Ewart, et al.
Nature Reviews. Drug Discovery
|
October 30, 2010
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
Shivanni Kummar, Helen X Chen, John Wright, et al.
Page
of 4